Clinical trial Recruiting at 1 site Observational Ages 18 to 65

Evaluating lung function in severe asthma patients with mucus plugs

Official title: Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Muco-Obstructive Lung Disease

Run by University of Kansas Medical Center · NCT06985225 · Data updated 2026-11-12

This study is testing how mucus plugs in the lungs affect breathing and airflow in people with severe asthma using special imaging techniques.

Quick facts

Study typeObservational
Ages18 Years to 65 Years
SexAll
Enrollment8 (estimated)
SponsorUniversity of Kansas Medical Center
Academic / other
Locations1 site (Kansas City, Kansas)
StatusRecruiting
StartedJune 1, 2025
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedJuly 1, 2026
Trial IDNCT06985225 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 65 with a physician diagnosis of asthma for over a year and specific blood eosinophil and FeNO levels.

Probably not a fit

Patients with significant concomitant medical illnesses or recent respiratory infections may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study uses xenon MRI to assess the impact of mucus plugs on lung ventilation and gas exchange in patients with severe asthma. Mucus plugs will be identified through CT imaging, and the study aims to evaluate the regional functional consequences of these plugs on lung function. Participants will undergo imaging to determine how these obstructions affect airflow and overall respiratory health.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and management of severe asthma by identifying specific ventilation defects caused by mucus plugs.

How similar studies have gone: While the use of xenon MRI in this context is relatively novel, similar imaging techniques have shown promise in evaluating lung function in other respiratory conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adequate completion of informed consent process with written documentation
* Patients 18 - 65 years old
* • Physician diagnosis of muco-obstructive pulmonary disease, including cystic fibrosis, severe asthma, chronic obstructive pulmonary disease, or non-cystic fibrosis bronchiectasis for \> 1 year
* Able to perform reproducible spirometry according to ATS criteria based on clinical PFTs.

Exclusion Criteria:

* Respiratory tract infection within the 4 weeks prior to Visit 1
* Body mass index (BMI) \> 30 at Visit 1
* One-time doses such as intra-articular injections require a 4-week washout prior to Visit 1
* ER visit related to pulmonary condition within the previous 4 weeks of Visit 1
* Significant concomitant medical illness, including (but not limited to) heart disease, cancer, uncontrolled diabetes, other chronic lung diseases (determined by the Investigator.)
* Resting O2 saturation \<90% with maximum supplemental O2 delivered by nasal canula
* Positive urine pregnancy test
* Participation in an intervention study (including bronchoscopy) or use of investigative drugs within the past 30 days or plans to enroll in such a trial during the study
* Unable or unlikely to complete study assessments in the opinion of the Investigator
* Study intervention poses undue risk to patient in the opinion of the Investigator
* Conditions that will prohibit MRI scanning determined by the MRI safety screening.

Where it's running

  • University of Kansas Medical Center
    Kansas City, Kansas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.